Clinical trial

Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

NCT05762900

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-10-25

PhasePHASE2

Study timeline

Study start (actual)2022-10-25Date precision: day

Registry last updated2023-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Radiotherapy Side Effectunresolved

Interventions

Ultra-fractionated radiation therapyRADIATION

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05762900 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.